Evidence map›Paper›PMID 34521382›Full record

ArticleBMC infectious diseases2021

The burden of drug resistant tuberculosis in a predominantly nomadic population in Uganda: a mixed methods study.

Brenda Nakafeero Simbwa, Achilles Katamba, Elizabeth B Katana, Eva A O Laker, Sandra Nabatanzi, Emmanuel Sendaula, Denis Opio, Jerry Ictho, Peter Lochoro, Charles A Karamagi and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Brenda Nakafeero SimbwaClinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda. nakafeerob@gmail.com.
Achilles KatambaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Elizabeth B KatanaClinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda.
Eva A O LakerInfectious Disease Institute, Kampala, Uganda.
Sandra NabatanziClinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda.
Emmanuel SendaulaClinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda.
Denis OpioClinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda.
Jerry IcthoDoctors with Africa, CUAMM, Kampala, Uganda.
Peter LochoroDoctors with Africa, CUAMM, Kampala, Uganda.
Charles A KaramagiClinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda.
Joan N KalyangoClinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda.
William WorodriaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Makerere University · UGDoctors with Africa Cuamm · ITInfectious Diseases Institute · UGMulago Hospital · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmergence of drug resistant tuberculosis (DR-TB) has aggravated the tuberculosis (TB) public health burden worldwide and especially in low income settings. We present findings from a predominantly nomadic population in Karamoja, Uganda with a high-TB burden (3500 new cases annually) and sought to determine the prevalence, patterns, factors associated with DR-TB.

methodsWe used mixed methods of data collection. We enrolled 6890 participants who were treated for tuberculosis in a programmatic setting between January 2015 and April 2018. A cross sectional study and a matched case control study with conditional logistic regression and robust standard errors respectively were used to the determine prevalence and factors associated with DR-TB. The qualitative methods included focus group discussions, in-depth interviews and key informant interviews.

resultsThe overall prevalence of DR-TB was 41/6890 (0.6%) with 4/64,197 (0.1%) among the new and 37/2693 (1.4%) among the previously treated TB patients respectively. The drug resistance patterns observed in the region were mainly rifampicin mono resistant (68.3%) and Multi Drug-Resistant Tuberculosis (31.7%). Factors independently associated with DR-TB were previous TB treatment, adjusted odds ratio (aOR) 13.070 (95%CI 1.552-110.135) and drug stock-outs aOR 0.027 (95%CI 0.002-0.364). The nomadic lifestyle, substance use, congested homesteads and poor health worker attitudes were a great challenge to effective treatment of TB.

conclusionDespite having the highest national TB incidence, Karamoja still has a low DR-TB prevalence. Previous TB treatment and drug stock outs were associated with DR-TB. Regular supply of anti TB medications and health education may help to stem the burden of TB disease in this nomadic population.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsCase-Control StudiesCross-Sectional StudiesHumansPrevalenceRifampinUgandaAntitubercular AgentsRifampinAlcoholDrug resistant TuberculosisDrug stock outGene-XpertKaramojaLow prevalenceNomadicStigmaUganda

Identifiers

PMID34521382
PMCPMC8442422
OpenAlexW3157047308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.